Diagnostic Accuracy and Efficiency

The difference of setting the patient on the right clinical path through timely and accurate diagnosis

Background Image
Form from the top
tabs dropdown arrow
Challenges

Poor diagnostic results can lead to improper diagnoses, delays in treatment or other consequences

  • 12 million

    Adults are affected by outpatient diagnostic errors in the United States annually 6

  • Up to 75%

    Of lab diagnostic errors occur in the preanalytical phase 7,8

  • 30–50%

    Of all antibiotics prescribed aren't needed or aren't optimally effective as prescribed 9,11

To set patients on the right clinical path, a timely and accurate diagnosis is crucial
To set patients on the right clinical path, a timely and accurate diagnosis is crucial

With access to high-quality results in less time, clinicians can feel confident that accurate information is informing a more optimal diagnosis and treatment plan. Discover how the right results can lead to a shorter length of stay and a better experience for everyone.

Explore

Explore the BD® Diagnostic Accuracy and Efficiency Program


            

Overview Overview
Overview
Technologies Technologies
Technologies
Goals Goals
Goals
Approach Approach
Approach

The BD® Diagnostic Accuracy and Efficiency Program can help you optimize the process from specimen collection through the delivery of lab results and recommends BD solutions to help you minimize errors and complications, like specimen contamination and retesting.

Through our BD® Diagnostic Accuracy and Efficiency Program, we use a baseline assessment to provide recommendations on BD solutions that can address identified gaps and improve performance in people, processes and technologies. Our technologies are designed to drive better outcomes from preparation through reporting results.

Toward better results

  • Reducing lab turnaround time and emergency department (ED) length of stay 
  • Minimizing specimen contamination rate 
  • Improving patient and healthcare worker experience 
  • Maximizing diagnostic accuracy

Actionable insights from an industry leader

  • Reviewing current practices and policies through clinical assessments from specimen collection through delivery of lab results
  • Providing recommendations based on a baseline assessment of how BD solutions can address identified gaps and improve performance in people, processes and technologies
  • Helping clinicians adhere to best practice through training and education
Discover

Discover how to help set patients on the right clinical path


            

Prep Prep
Prep
Collect Collect
Collect
Analyze Analyze
Analyze
Report Report
Report
<p>Proper cleaning and decontamination of a patient's skin, such as before providing a urine sample or drawing a blood sample, helps reduce contamination rates. 44% of ER patients and inpatients were prescribed inappropriate antibiotics due to contaminated urine cultures.<sup>1</sup></p>
<p><span class="forward-arrow-icon"><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/chloraprep-swabstick.html">BD ChloraPrep™ swabstick </a><span class="boostedblue-font-color"></span></span></p>

Proper cleaning and decontamination of a patient's skin, such as before providing a urine sample or drawing a blood sample, helps reduce contamination rates. 44% of ER patients and inpatients were prescribed inappropriate antibiotics due to contaminated urine cultures.1

BD ChloraPrep™ swabstick 

<p>The specimen collection method can impact specimen integrity.</p>
<p>56% of blood collections are from patients with diagnoses associated with difficult venous access<sup>2</sup> <i>(e.g., cancer, chronic cardiovascular disease, chronic kidney disease, diabetes, blood disorders/anemias and obesity)</i>.</p>
<p><a href="https://bdveritor.bd.com/en-us" target="_blank"><span class="forward-arrow-icon-boosted-blue"><span class="boostedblue-font-color">BD Vacutainer<sup>®</sup> UltraTouch™ push button blood collection set</span></span></a></p>

The specimen collection method can impact specimen integrity.

56% of blood collections are from patients with diagnoses associated with difficult venous access2 (e.g., cancer, chronic cardiovascular disease, chronic kidney disease, diabetes, blood disorders/anemias and obesity).

BD Vacutainer® UltraTouch™ push button blood collection set

<p>The testing method, timing and process can impact the time to reporting. A 10-minute reduction in lab result turnaround time = 6.7 minute reduction in ED length of stay.<sup>4&nbsp;</sup></p>
<p><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/bd-bactec-fx-blood-culture-system.html" target="_blank"><span class="forward-arrow-icon-boosted-blue"><span class="boostedblue-font-color">BD BACTEC™&nbsp;FX blood culture system</span></span></a></p>
<p><a href="https://go.bd.com/FACSLyric-system.html" target="_blank"><span class="boostedblue-font-color"><span class="forward-arrow-icon-boosted-blue">BD FACSLyric™&nbsp;clinical flow cytometry system</span></span></a></p>
<p><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/bd-kiestra-total-lab-automation-tla-system.html"><span class="forward-arrow-icon-boosted-blue"><span class="boostedblue-font-color">BD Kiestra™&nbsp;lab automation solutions</span></span></a></p>
<p><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/bd-max-system.html"><span class="boostedblue-font-color"><span class="forward-arrow-icon-boosted-blue">BD MAX™&nbsp;system</span></span></a></p>
<p><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/bd-phoenix-m50-instrument.html"><span class="forward-arrow-icon-boosted-blue"><span class="boostedblue-font-color">BD Phoenix™&nbsp;automated identification and susceptibility testing system</span></span></a></p>
<p><a href="https://bdveritor.bd.com/en-us" target="_blank">BD Veritor™ System</a></p>
<p><a href="https://cervicalcancer.bd.com/products-cor.html" target="_blank">BD COR™ System</a></p>

The testing method, timing and process can impact the time to reporting. A 10-minute reduction in lab result turnaround time = 6.7 minute reduction in ED length of stay.

BD BACTEC™ FX blood culture system

BD FACSLyric™ clinical flow cytometry system

BD Kiestra™ lab automation solutions

BD MAX™ system

BD Phoenix™ automated identification and susceptibility testing system

BD Veritor™ System

BD COR™ System

<p>Time to reporting of results can have an impact on clinical decisions and therefore patient treatment. Many physicians surveyed believed that laboratory turnaround time caused delayed ED treatment more than 50% of the time and increased ED length of stay more than 50% of the time.<sup>5</sup></p>
<p><a href="https://medmined.bd.com/" target="_blank"><span class="forward-arrow-icon-boosted-blue"><span class="boostedblue-font-color">BD MedMined™ Surveillance Advisor</span></span></a></p>
<p><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/bd-synapsys-informatics-solution.html" target="_blank"><span class="boostedblue-font-color"><span class="forward-arrow-icon-boosted-blue">BD Synapsys™ Microbiology Informatics Solution</span></span></a></p>

Time to reporting of results can have an impact on clinical decisions and therefore patient treatment. Many physicians surveyed believed that laboratory turnaround time caused delayed ED treatment more than 50% of the time and increased ED length of stay more than 50% of the time.5

BD MedMined™ Surveillance Advisor

BD Synapsys™ Microbiology Informatics Solution

Prep Related Products
  • ChloraPrep™ swabstick

    The ChloraPrep™ swabstick promotes aseptic surgical skin prep technique prior to surgery or injection. The easy-to-use foam tip is saturated with the clear ChloraPrep™ solution.

    Learn More

    forward-arrow
Collect Related Products
  • BD Vacutainer® UltraTouch™ push button blood collection set

    With propriety BD PentaPoint™ and BD RightGauge™ needle technology, the BD Vacutainer® UltraTouch™ push button blood collection set aims to improve the patient experience by enhancing comfort, enabling clinicians to better access difficult veins, and reducing overall procedure times.

    Learn More

    forward-arrow
  • Urine Specimen Collection

    BD urine specimen kits offer a closed system that reduces the risk of specimen contamination and associated false readings.

    Learn More

    forward-arrow
  • BD Vacutainer® blood collection tubes

    BD is the inventor of BD Vacutainer® blood collection tubes as well as the worldwide leader in blood tubes. We support our products with extensive clinical expertise and educational materials to help you achieve the best possible results.

    Learn More

    forward-arrow
Analyze Related Products
  • BD BACTEC™ FX blood culture system

    The BD BACTEC™ FX blood culture system builds on the proven history of previous BD BACTEC™ instrumentation, with advanced fluorescence detection technology, exceptional media performance and instrument reliability—adding vial-activated workflow, advanced ergonomics, blood culture observation and customer-focused data management.

    Learn More

    forward-arrow
  • BD Kiestra™ InoqulA sample processor

    The specimen processor automates the processing of both liquid and non-liquid sample types.

    Learn More

    forward-arrow
  • BD Kiestra™ ReadA

    Intelligent incubation and imaging system. Standardize incubation, imaging and results interpretation.

    Learn More

    forward-arrow
  • BD Kiestra™ Total Lab Automation (TLA) System

    Scalable solution to help you enhance laboratory operations and advance laboratory operations.

    Learn More

    forward-arrow
  • BD Kiestra™ Urine Culture Application

    An application developed with Artificial Intelligence (AI) that enables high resolution and standardized plate imaging to deliver laboratory efficiencies and advanced image analysis.

    Learn More

    forward-arrow
  • BD Kiestra™ Work Cell Automation (WCA) System

    A modular, automated solution designed for microbiology laboratories of all sizes.

    Learn More

    forward-arrow
  • BD MAX™ system

    The BD MAX™ system offers you an efficient path to improved clinical outcomes by combining and automating extraction and thermocycling into a single platform capable of running both FDA-cleared and open system assays. Flexibility and standardization allow you to address the breadth of your testing needs.

    Learn More

    forward-arrow
  • BD Phoenix™ M50 instrument

    The BD Phoenix™ M50 instrument provides clinicians with accurate and timely identification and susceptibility results to help guide their therapy and patient management decisions.

    Learn More

    forward-arrow
  • BD FACSLyric™ clinical flow cytometry system

    Enable powerful, innovative and efficient flow cytometry for your clinical or research lab

    Learn More

    forward-arrow
  • BD COR™ System

    Delivering efficiency, flexibility and performance to meet your laboratories' evolving molecular diagnostic needs.

    Learn more

    forward-arrow
  • BD Veritor™

    Two testing solutions offering reliable results with the same hospital-grade technology that doctors trust.

    Learn More

    forward-arrow
Report Related Products
  • BD Synapsys™

    BD Synapsys™ solution enables laboratories to address challenges and improve laboratory outcomes. It enables labs to maximize performance using enhanced microbiology diagnostic informatics through a single, advanced platform with an intuitive, personalized user interface. BD Synapsys solution offers integrated workflow and on-demand insights to empower laboratory staff to impact turnaround time, expedite decision making, improve productivity and simplify compliance.

    Learn More

    forward-arrow
  • BD HealthSight™ Clinical Advisor and Infection Advisor with MedMined™ Insights

    BD HealthSight™ Clinical Advisor and BD HealthSight™ Infection Advisor with MedMined™ Insights are enterprise-wide, e-surveillance and clinical notification solutions allowing users to select the information most actionable for their healthcare site.

    Learn More

    forward-arrow
References
  1. Klausing BT, Tillman SD, Wright PW, Talbot TR. The influence of contaminated urine cultures in inpatient and emergency department settings. Am J Infect Control. 2016;44(10):1166-1167. doi: 10.1016/j.ajic.2016.03.055

  2. Data on File: REF-1882 BD Venipuncture Burden Insurance Data, U.S. 2012.

  3. Bryan C. Urinary tract infections. In: Hunt R. Infectious Disease. Microbiology and Immunology On-line. University of South Carolina School of Medicine; 2017. Urinary Tract Infections . Accessed April 17, 2017.

  4. Mitra D, Erdal E, Khangulov V, Tuttle R. Association between laboratory test turnaround time and emergency department length of stay: a retrospective US electronic health database analysis. Poster session presented at: American Association for Clinical Chemistry 2015 Annual Meeting and Clinical Lab Expo; July 26-30, 2015; Atlanta, GA.

  5. Steindel SJ, Howanitz PJ. Physician satisfaction and emergency department laboratory test turnaround time. Arch Pathol Lab Med. 2001;125(7):863-871.
  6. Singh H, Meyer AN, Thomas EJ. The frequency of diagnostic errors in outpatient care: estimations from three large observational studies involving US adult populations. BMJ Qual Saf. 2014;23(9):727-731. doi: 10.1136/bmjqs-2013-002627
  7. Lippi G, Chance JJ, Church S, et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med. 2011;49(7):1113-1126. doi:10.1515/CCLM.2011.600
  8. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem. 2002;48(5):691-698.
  9. Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2013. https://www.cdc.gov/drugresistance/threat-report-2013. Published September 16, 2013. Accessed September 18, 2018.
  10. Centers for Disease Control and Prevention (CDC). 1 in 3 antibiotic prescriptions unnecessary CDC Newsroom .  Last reviewed January 1, 2016. Accessed 18, 2018.
  11.  Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA. 2016;315(17):1864-1873.

Provide your information to download resources

Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday
×